TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 4 | 7 | 23 | 19 | 8 | 7 | 11 |
| P | %wins | 100 | 67 | 100 | 67 | 67 | 50 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/6/22 16:35 | 6/24/22 | QTNT | Quotient Ltd | Y9 | Health | Diagn | In Vitro & In Vivo Diagnostic | Wilkerson L John | CT | D | P.d | 1,400 | 0.3000 | 0 | 4,667 | 63 | 12,091 | I | |||||||||||||||
8/5/16 11:30 | 8/3/16 | QTNT | Quotient Ltd | Y9 | Health | Diagn | In Vitro & In Vivo Diagnostic | Wilkerson L John | CT | DT | P.d | 990 | 5.50 | 0 | 180 | 3 | 6,490 | I | -33 | -65 | -40 | -37 | -33 | -16 | -20 | 5 | 1 | -1 | 0 | -20 | 9 | ||
2/11/16 16:58 | 2/10/16 | QTNT | Quotient Ltd | Y9 | Health | Diagn | In Vitro & In Vivo Diagnostic | Wilkerson L John | CT | DT | P.d | 2,000 | 9.00 | 1 | 222 | 4 | 6,310 | I | -59 | -58 | -46 | -57 | -50 | -43 | -8 | 8 | 15 | 15 | 31 | -19 | -14 | ||
12/2/14 17:53 | 11/28/14 | QTNT | Quotient Ltd | Health | Diagn | In Vitro & In Vivo Diagnostic | Wilkerson L John | Y9 | DT | P.d | 1,500 | 9.50 | 0 | 158 | 3 | 5,837 | I | 61 | 26 | 22 | 11 | -9 | -27 | 2 | 8 | 55 | 45 | 35 | 27 | ||||
5/1/14 19:43 | 4/30/14 | QTNTU | Quotient Ltd | Health | Diagn | In Vitro & In Vivo Diagnostic | Wilkerson L John | Y9 | DT | P.d | 0 | 0.00 | 0 | 313 | 6 | 5,680 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |